Results 41 to 50 of about 1,229,139 (304)

ABC of oral health: Oral cancer [PDF]

open access: yesBMJ, 2000
Most mouth cancer is oral squamous cell carcinoma. This is uncommon in the developed world, except in parts of France, but is common in the developing world, particularly South East Asia and Brazil. It is mainly seen in men over middle age (though it is increasing in younger people), tobacco users, and lower socioeconomic groups.
C, Scully, S, Porter
openaire   +2 more sources

Oral cancer secretome: Identification of cancer-associated proteins [PDF]

open access: yes, 2014
This study aims to identify cancer-associated proteins in the secretome of oral cancer cell lines. We have successfully established four primary cell cultures of normal cells with a limited lifespan without human telomerase reverse transcriptase (hTERT ...
Chang, H. Y.   +6 more
core   +1 more source

Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report. [PDF]

open access: yes, 2015
Regorafenib, an oral multikinase inhibitor, was approved in September 2012 by the US Food and Drug Administration for the treatment of patients with metastatic colorectal cancer.
Herman, June   +3 more
core   +3 more sources

Limocitrin induced cellular death through ERK pathways in human oral squamous cell cancer

open access: yesScientific Reports
This study sought to investigate the anticancer efficacy of limocitrin on two distinct human oral cancer cell lines. At first, we evaluated the effect of limocitrin on the proliferation of OSCC cells (SCC-9 and SCC-47) using MTT and colony formation ...
Bharath Kumar Velmurugan   +6 more
doaj   +1 more source

Oral cancer in the UK: to screen or not to screen. [PDF]

open access: yes, 1998
Although oral squamous cell carcinoma accounts for only a small proportion of malignant neoplasms in the UK, oral cancer incidence and mortality rates have been rising in recent years.
Rodrigues, Veena
core  

Oral cancer cells may rewire alternative metabolic pathways to survive from siRNA silencing of metabolic enzymes. [PDF]

open access: yes, 2014
BackgroundCancer cells may undergo metabolic adaptations that support their growth as well as drug resistance properties. The purpose of this study is to test if oral cancer cells can overcome the metabolic defects introduced by using small interfering ...
Brumbaugh, Jeffrey   +8 more
core   +1 more source

The Efficacy and Safety of Bevacizumab/Irinotecan/Temozolomide (BIT) for Relapsed/Refractory Neuroblastoma: The UK Children's Cancer and Leukaemia Group Experience

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Patients with high‐risk neuroblastoma who either are refractory to induction chemotherapy or relapse following multi‐modal treatment have a dismal prognosis. Based on data from the BEACON trial, since 2021 the UK national guidelines recommend bevacizumab, irinotecan, and temozolomide (BIT) for patients with relapsed/refractory ...
Thomas J. Jackson   +20 more
wiley   +1 more source

Oral microbiota and oral cancer: Review

open access: yesOncology Reviews, 2020
In this review, we draw attention and discuss the risk factors and causes of the development of oral squamous cell carcinoma (OSCC) focusing on oral microbiota. Recently, a breakthrough in the study of cancer has been the discovery of the relationship between the presence of certain types of bacteria and the development of cancer in the human body ...
Mariam Z. Kakabadze   +4 more
openaire   +4 more sources

Interventions for preventing oral mucositis for patients with cancer receiving treatment [PDF]

open access: yes, 2010
Interventions for preventing oral mucositis for patients with cancer receiving treatmentTreatment for cancer (including bone marrow transplant) can cause oral mucositis (severe ulcers in the mouth). This painful condition can cause difficulties in eating,
Abramoff   +379 more
core   +6 more sources

The newfound relationship between extrachromosomal DNAs and excised signal circles

open access: yesFEBS Letters, EarlyView.
Extrachromosomal DNAs (ecDNAs) contribute to the progression of many human cancers. In addition, circular DNA by‐products of V(D)J recombination, excised signal circles (ESCs), have roles in cancer progression but have largely been overlooked. In this Review, we explore the roles of ecDNAs and ESCs in cancer development, and highlight why these ...
Dylan Casey, Zeqian Gao, Joan Boyes
wiley   +1 more source

Home - About - Disclaimer - Privacy